Exhibit 1

Harris

Ametek

06/29/07

Anheuser

12/31/06

Apple

12/31/06

09/30/06

Income Statement
Sales

$4,243.00

$1,819.30

$15,717.10

$19,315.00

Cost of Goods

$2,871.10

$1,251.90

$10,165.00

$13,717.00

Gross Margin (GM)

$1,371.90

$567.40

$5,552.10

$5,598.00

R&D
Marketing

$269.30
$

$88.00 $
$

$712.00

G&A

$561.40

$170.40

$2,832.50

$2,433.00

Total SG&A

$830.70

$258.40

$2,832.50

$3,145.00

EBIT

$541.20

$309.00

$2,719.60

$2,453.00

Taxes, Int., etc.

$60.80

$127.10

$1,343.20

$464.00

Net Income

$480.40

$181.90

$1,376.40

$1,989.00

Depr. & Amort.

$135.20

$45.90

$988.70

$225.00

EBITDA

$676.40

$354.90

$3,708.30

$2,678.00

Cash

$429.20

$58.20

$219.20

$10,110.00

Receivables

$748.50

$328.80

$720.20

$1,252.00

Inventory

$347.10

$236.80

$694.90

$270.00

Other Current

$304.00

$60.30

$195.20

$2,877.00

PP&E (Net)

$459.20

$258.00

$8,916.10

$1,281.00

Other Non-current

$2,118.00

$1,188.80

$5,631.60

$1,415.00

Total Assets

$4,406.00

$2,130.90

$16,377.20

$17,205.00

$350.00

$160.60

$1,426.30

$3,390.00

$1,288.10

$320.30

$819.80

$3,081.00

$864.10

$683.30

$10,192.40

$750.00

Total Liabilities

$2,502.20

$1,164.20

$12,438.50

$7,221.00

Equity

$1,903.80

$966.70

$3,938.70

$9,984.00

Total Liab. and Equity

$4,406.00

$2,130.90

$16,377.20

$17,205.00

Market Capitalization

$8,030.70

$4,672.70

$37,584.90

$135,709.80

16.7

25.7

27.3

68.2

Balance Sheet

Payables
Other Short Term
Non-current

P/E Ratio
Price/Sales
5 Yr Sales Growth
Ind. 5 Yr Sales Growth
5 Yr NI Growth
Ind. 5 Yr NI Growth

1.9

2.6

2.4

18.2

12.3

29.2

9.3

8.7

23.9

40.7

22.4

2.9

95

12.3

31.5

9.6

5.1

GM/Sales

32.30%

31.20%

35.30%

29.00%

EBIT/Sales

12.80%

17.00%

17.30%

12.70%

EBITDA/Sales

15.90%

19.50%

23.60%

13.90%

ROE

25.20%

18.80%

34.90%

19.90%

ROS

11.30%

10.00%

8.80%

10.30%

0.96

0.85

0.96

1.12

Return on Assets

10.90%

8.50%

8.40%

11.60%

RONWC

32.50%

34.80%

341.40%

17.90%

GMRONWC%

184.00%

140.10%

-49572.30%

-299.70%

# of Employees

16,000

10,400

30,183

17,787

$265,188

$174,932

$520,727

$1,085,905

GM/Employee

$85,744

$54,555

$183,948

$314,724

EBIT/Employee

Speed (Asset Turnover)

Revenue/Employee

$33,825

$29,712

$90,104

$137,910

R&D/Sales

6.30%

4.80%

0.00%

3.70%

Marketing/Sales

0.00%

0.00%

0.00%

0.00%

G&A/Sales

13.20%

9.40%

18.00%

12.60%

SG&A/Sales

19.60%

14.20%

18.00%

16.30%

R&D/GM

19.60%

15.50%

0.00%

12.70%

0.00%

0.00%

0.00%

0.00%

G&A/GM

40.90%

30.00%

51.00%

43.50%

SG&A/GM

Marketing/GM

60.60%

45.50%

51.00%

56.20%

Receivable Turnover

5.7

5.5

21.8

15.4

Inventory Turnover

8.3

5.3

14.6

50.8

0.9

1.1

Receivable Days

64.4

66

16.7

23.7

Inventory Days

44.1

69

25

7.2

Payable Days

44.5

46.8

51.2

90.2

64

88.2

-9.5

-59.4

Asset Turnover

NWC Days

AstraZeneca

Best Buy

12/31/06

Boeing

03/30/07

12/31/06

$26,475.00

$35,934.00

$61,530.00

$5,559.00

$27,165.00

$50,437.00

$20,916.00

$8,769.00

$11,093.00

$3,902.00 $

$3,257.00
$

$8,798.00

$6,770.00

$4,171.00

$12,700.00

$6,770.00

$7,428.00

$8,216.00

$1,999.00

$3,665.00

$3,824.00

$622.00

$1,459.00

$4,392.00

$1,377.00

$2,206.00

$1,345.00

$509.00

$1,545.00

$9,561.00

$2,508.00

$5,210.00

$7,760.00

$3,793.00

$6,386.00

$6,159.00

$548.00

$5,655.00

$2,250.00

$4,028.00

$8,105.00

$767.00

$712.00

$2,837.00

$7,453.00

$2,938.00

$7,675.00

$5,543.00

$1,551.00

$21,136.00

$29,932.00

$13,570.00

$51,794.00

$3,482.00

$3,934.00

$16,201.00

$5,965.00

$2,367.00

$13,500.00

$5,181.00

$1,068.00

$17,354.00

$14,628.00

$7,369.00

$47,055.00

$15,304.00

$6,201.00

$4,739.00

$29,932.00

$13,570.00

$51,794.00

$76,755.00

$22,496.00

$83,424.90

17.5

16.3

37.8

2.9

0.6

1.4

10.3

15.2

1.1

7.1

18.1

8.4

26.3

19.3

-4.8

6.9

27.6

58.4

79.00%

24.40%

18.00%

31.00%

5.60%

6.00%

36.10%

7.00%

8.50%

28.70%

22.20%

46.50%

16.60%

3.80%

3.60%

0.88

2.65

1.19

14.70%

10.10%

4.30%

32.60%

26.80%

32.50%

424.50%

1365.90%

-454.40%

66,800

140,000

154,000

$396,332

$256,671

$399,545

$313,114

$62,636

$72,032

$122,994

$14,279

$23,799

14.70%

0.00%

5.30%

0.00%

0.00%

0.00%

33.20%

18.80%

6.80%

48.00%

18.80%

12.10%

18.70%

0.00%

29.40%

0.00%

0.00%

0.00%

42.10%

77.20%

37.60%

60.70%

77.20%

67.00%

4.3

65.6

10.9

2.5

6.7

6.2

0.9

2.6

1.2

84.9

5.6

33.5

147.7

54.1

58.7

228.6

52.9

117.2

6.8

-25

Exhibit 2
Top 25 Supply
Chain

Sales Growth
Leader

NI Growth
Leader

Competitor

Ametek Inc.

--

--

--

Anheuser-Busch

--

--

--

Apple Computer

--

Best Buy

--

--

--

Boeing

--

--

--

Brady Corp

--

--

Ceradyne Inc.

--

--

Cisco

--

--

Coca-Cola

--

--

--

Danaher Corp.

--

--

Dover Corp.

--

--

DRS Technology

--

General Dynamic

--

--

Garmin Ltd.

--

--

GlaxoSmithKline

--

--

Hewlett-Packard

--

IBM

--

--

--

ITT

--

--

Johnson & Johnson

--

Johnson Controls

--

KLA Tencor Corp.

--

--

--

L-3 Communications

--

Lincoln Electric Holdings Inc.

--

--

Lockheed Martin

Lowes

--

Motorola

NetApp, Inc.

--

--

Nike

--

--

--

Nokia

--

Paccar

--

PepsiCo

--

--

Proctor & Gamble

--

Precision Castparts Corp.

--

--

--

Publix Super Markets

--

--

Qualcomm Inc.

--

--

Raytheon

--

--

Rockwell Collins

--

--

Stanley Works

--

--

--

Texas Instruments

--

--

Toyota Motor

--

United Technologies Co.

--

Company

ViaSat Inc.

--

Wal-Mart

--

# companies in group

23

29

33

12

Note: Y= Yes, the company is in that group

Growth Leader Small Company Elite Company

Large Elite

Small Elite

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

--

-Y

--

--

--

--

--

24

16

12

Exhibit 3
Harris

Elites

Large Elite

Small Elite

Income Statement
Sales

$4,243.00

$1,000,800.90

$723,571.80

$277,229.10

Cost of Goods

$2,871.10

$705,652.40

$536,299.00

$169,353.40

Gross Margin(GM)

$1,371.90

$295,148.50

$187,272.80

$107,875.70

$269.30

$30,269.10

$12,714.50

$17,554.60

R&D
Marketing

$7,937.00

$7,937.00 $

G&A

$561.40

$153,045.70

$104,573.60

$48,472.10

Total SG&A

$830.70

$191,251.80

$125,225.10

$66,026.70

EBIT

$541.20

$103,896.70

$62,047.70

$41,849.00

$60.80

$32,625.70

$20,029.70

$12,596.00

Net Income

$480.40

$71,271.00

$42,018.00

$29,253.00

Depr. & Amort.

$135.20

$30,054.90

$22,880.50

$7,174.40

EBITDA

$676.40

$133,951.50

$84,928.10

$49,023.40

Cash

$429.20

$93,401.40

$49,751.20

$43,650.20

Receivables

$748.50

$122,440.30

$79,308.60

$43,131.70

Inventory

$347.10

$85,627.60

$63,830.90

$21,796.70

Other Current

$304.00

$45,093.00

$27,746.20

$17,346.80

PP&E (Net)

$459.20

$238,282.70

$184,444.20

$53,838.50

Other Noncurrent

$2,118.00

$317,933.10

$247,384.60

$70,548.50

Total Assets

$4,406.00

$902,778.20

$652,465.80

$250,312.40

$350.00

$95,062.40

$64,998.70

$30,063.70

$1,288.10

$206,811.50

$154,929.90

$51,881.60

$864.10

$216,056.50

$163,857.60

$52,198.90

Total Liabilities

$2,502.20

$517,930.30

$383,786.10

$134,144.20

Equity

$1,903.80

$384,847.90

$268,679.70

$116,168.20

Total Liab. & Equity

$4,406.00

$902,778.20

$652,465.80

$250,312.40

$8,030.70

$1,302,859.40

$722,812.00

$580,047.40

16.7

18.3

17.2

19.8

Taxes, Int., etc.

Balance Sheet

Payables
Other Short Term
Noncurrent

Ratios
Market Capitalization
P/E Ratio
Price/Sales
5 Yr Sales Growth
Ind. 5 Yr Sales Growth
5 Yr NI Growth
Ind. 5 Yr NI Growth

1.9

1.3

2.1

18.2

14.3

12.8

15.1

9.3

10.9

9.6

11.5

40.7

44.6

28.1

52.8

12.3

17.3

16.5

17.6

GM/Sales

32.30%

29.50%

25.90%

38.90%

EBIT/Sales

12.80%

10.40%

8.60%

15.10%

EBITDA/Sales

15.90%

13.40%

11.70%

17.70%

ROE

25.20%

18.50%

15.60%

25.20%

ROS

11.30%

7.10%

5.80%

10.60%

0.96

1.11

1.11

1.11

Return on Assets

10.90%

7.90%

6.40%

11.70%

RONWC

32.50%

28.30%

27.00%

30.50%

Speed (asset turns)

GMRONWC%

184.00%

261.20%

239.70%

309.40%

# of Employees

16,000

3,337,968

2,593,394

744,574

$265,188

$299,823

$279,006

$372,333

GM/Employee

$85,744

$88,422

$72,211

$144,882

EBIT/Employee

Revenue/Employee

$33,825

$31,126

$23,925

$56,205

R&D/Sales

6.30%

3.00%

1.80%

6.30%

Marketing/Sales

0.00%

0.80%

1.10%

0.00%

G&A/Sales

13.20%

15.30%

14.50%

17.50%

SGA/Sales

19.60%

19.10%

17.30%

23.80%

R&D/GM

19.60%

10.30%

6.80%

16.30%

0.00%

2.70%

4.20%

0.00%

G&A/GM

40.90%

51.90%

55.80%

44.90%

SGA/GM

Marketing/GM

60.60%

64.80%

66.90%

61.20%

Receivable Turnover

5.7

8.2

9.1

6.4

Inventory Turnover

8.3

8.2

8.4

7.8

1.1

1.1

1.1

Receivable Days

64.4

44.7

40

56.8

Inventory Days

44.1

44.3

43.4

47

Payable Days

44.5

49.2

44.2

64.8

64

39.8

39.2

39

Asset Turnover

NWC Days

Top 25

Growth Ldr

Sales Ldr

Profit Ldr

Competitors

Small Cos

$1,354,768.60

$1,096,654.20

$1,148,618.00

$1,285,125.30

$304,818.50

$61,148.60

$897,348.70

$768,319.90

$804,307.30

$869,502.10

$232,174.70

$35,218.50

$457,419.90

$328,334.30

$344,310.70

$415,623.30

$72,643.70

$25,930.20

$50,768.10

$34,908.00

$37,744.20

$48,294.60

$15,611.20

$3,769.90

$7,937.00

$7,945.90

$7,990.30

$236,187.70

$167,342.50

$172,781.30

$207,187.00

$26,188.90

$11,305.70

$294,892.80

$210,196.40

$218,515.70

$263,427.50

$41,800.10

$15,128.90

$162,527.00

$118,137.90

$125,794.90

$152,195.80

$30,843.60

$10,801.20

$45,297.00

$37,073.30

$37,772.70

$45,407.70

$9,852.20

$2,574.90

$117,230.10

$81,064.60

$88,022.20

$106,788.10

$20,991.40

$8,226.30

$42,875.70

$32,345.30

$34,289.10

$36,956.00

$5,938.30

$1,735.80

$205,402.70

$150,483.20

$160,084.00

$189,151.80

$36,781.90

$12,537.00

$154,318.40

$105,112.70

$111,605.70

$148,968.60

$43,390.50

$11,994.10

$176,687.30

$135,840.00

$142,322.30

$157,800.20

$36,997.90

$10,338.10

$106,751.30

$98,823.20

$107,323.80

$113,439.70

$35,860.60

$6,998.70

$7,945.90 $

$53.30

$60,994.40

$48,934.10

$50,862.60

$57,483.30

$15,338.20

$2,930.00

$302,318.50

$249,841.30

$257,609.70

$279,119.10

$28,027.80

$8,683.30

$428,303.00

$374,314.80

$392,944.40

$433,539.40

$105,321.30

$35,372.40

$1,229,372.80

$1,012,866.20

$1,062,668.50

$1,190,350.20

$264,936.40

$76,316.60

$120,053.40

$102,491.70

$106,542.90

$113,545.80

$36,451.40

$5,190.10

$283,408.30

$225,386.80

$235,729.00

$264,501.90

$65,486.60

$11,777.00

$293,934.90

$246,126.40

$254,964.80

$281,571.10

$72,812.30

$14,963.20

$697,396.60

$574,004.80

$597,236.70

$659,618.80

$174,750.40

$31,930.30

$531,976.10

$438,861.30

$465,431.80

$530,731.50

$90,186.00

$44,386.30

$1,229,372.80

$1,012,866.20

$1,062,668.50

$1,190,350.20

$264,936.40

$76,316.60

$2,442,972.80

$1,546,673.80

$1,653,553.00

$2,316,765.00

$499,531.30

$214,509.80

20.8

19.1

18.8

21.7

23.8

26.1

1.8

1.4

1.4

1.8

1.6

3.5

11.3

21.3

19.7

17.8

14.8

22.2

10.5

10.7

10.3

11.1

8.6

12

36.6

46.8

41.7

52.1

56.6

43.2

17.3

16.1

20.8

17.6

30.9

22.5

33.80%

29.90%

30.00%

32.30%

23.80%

42.40%

12.00%

10.80%

11.00%

11.80%

10.10%

17.70%

15.20%

13.70%

13.90%

14.70%

12.10%

20.50%

22.00%

18.50%

18.90%

20.10%

23.30%

18.50%

8.70%

7.40%

7.70%

8.30%

6.90%

13.50%

1.1

1.08

1.08

1.08

1.15

0.8

9.50%

8.00%

8.30%

9.00%

7.90%

10.80%

31.00%

28.30%

28.80%

29.30%

22.10%

30.40%

280.00%

248.40%

240.60%

263.60%

199.50%

213.50%

4,580,311

3,730,648

3,910,034

4,439,482

979,697

242,393

$295,781

$293,958

$293,762

$289,476

$311,135

$252,271

$99,867

$88,010

$88,058

$93,620

$74,149

$106,976

$35,484

$31,667

$32,172

$34,282

$31,483

$44,561

3.70%

3.20%

3.30%

3.80%

5.10%

6.20%

0.60%

0.70%

0.70%

0.60%

0.00%

0.10%

17.40%

15.30%

15.00%

16.10%

8.60%

18.50%

21.80%

19.20%

19.00%

20.50%

13.70%

24.70%

11.10%

10.60%

11.00%

11.60%

21.50%

14.50%

1.70%

2.40%

2.30%

1.90%

0.00%

0.20%

51.60%

51.00%

50.20%

49.80%

36.10%

43.60%

64.50%

64.00%

63.50%

63.40%

57.50%

58.30%

7.7

8.1

8.1

8.1

8.2

5.9

8.4

7.8

7.5

7.7

6.5

1.1

1.1

1.1

1.1

1.2

0.8

47.6

45.2

45.2

44.8

44.3

61.7

43.4

46.9

48.7

47.6

56.4

72.5

48.8

48.7

48.3

47.7

57.3

53.8

42.2

43.5

45.6

44.8

43.4

80.5

All

$1,582,107.10
$1,063,714.90
$518,392.20
$60,494.80
$7,990.30
$261,111.00
$329,596.00
$188,796.20
$54,028.70
$134,767.50

$48,134.60
$236,930.80

$181,952.70
$203,135.40
$141,341.10
$69,736.90
$329,436.90
$540,175.10
$1,465,778.00

$149,091.60
$333,161.60
$358,892.50
$841,145.70
$624,632.30
$1,465,778.00

$2,897,078.40
21.5
1.8
15.6
10.8
41.9
21.8
32.80%
11.90%
15.00%
21.60%

8.50%
1.08
9.20%
30.10%
265.30%
5,400,017
$292,982
$95,998
$34,962
3.80%
0.50%
16.50%
20.80%
11.70%
1.50%
50.40%
63.60%
7.8
7.5
1.1
46.9
48.5
51.2
44.2

Exhibit 4

Two Best-In-Class Company Benchmarks for each Focal Ra

Company

Ratio

AstraZeneca
GlaxoSK

GM/Sales

Qualcomm
Texas Instruments

ROS

Apple Computers
Paccar

Revenue/Employee

Qualcomm
Cisco

GM/Employee

Paccar
Precision Castparts

SG&A/Sales

GlaxoSK
Boeing

ROE

Apple Computers
Boeing

NWC Days

Lowes
L3 Communications

Receivable Days

Apple Computers
NetApp, Inc.

Inventory Days

AstraZeneca
Johnson & Johnson

Payable Days

marks for each Focal Ratio

Value

Harris

79.00%
78.40%

32.30%

32.80%
30.50%

11.30%

$1,086,000
$783,000

$265,000

$477,000
$363,000

$85,700

3.60%
6.50%

19.60%

47.50%
46.50%

25.20%

59 days
25 days

64 days

0 days
0 days

64.4 days

7.2 days
18.2 days

44.1 days

228.6 days
138.0 days

44.5 days